ESLT vs LHX: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

LHX is the larger of the two ($47.47B market cap): the incumbent the market prices for continued execution (18.68x forward earnings, beta 0.46). ESLT is the smaller challenger ($31.22B), actually pricier on forward earnings (32.69x): more room to run, but more to prove. If you believe in growth, ESLT fits: analysts expect its revenue to rise 17% next year, against 7% for LHX. If you believe in paying less for profit, LHX fits: it trades at 18.68x forward earnings, against 32.69x for ESLT.

ESLT vs LHX: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricESLTLHXWhat it tells you
Market cap$31.22B$47.47BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E32.6918.68Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E46.9323.74Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta-0.400.46Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range38% of range15% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book6.832.34How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: LHX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how ESLT and LHX affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ESLT and LHX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ESLT and LHX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Elbit Systems Ltd (ESLT) do?

Elbit Systems Ltd (Nasdaq and Tel Aviv: ESLT) is an Israel-based defense technology company that develops, manufactures, integrates and sustains military systems across land, sea, air, cyber and space domains. Its portfolio spans C4ISR (command, control and intelligence systems), electro-optics and thermal imaging, unmanned aerial and ground systems, precision munitions and artillery rockets (including its PULS launcher), helmet-mounted displays for pilots, and electronic warfare. The company employs about 21,000 people across five continents and generates a large share of sales from export customers, with roughly 72% of its order backlog attributable to orders from outside Israel as of the end of 2025.

Full ESLT guide

What does L3Harris Technologies (LHX) do?

L3Harris Technologies is a major US defense and aerospace contractor formed by the 2019 merger of L3 Technologies and Harris Corporation. It positions itself as an agile defense-technology company spanning communications, sensors, electronic warfare, space, intelligence, and missile systems. The business is organized into segments covering Space and Airborne Systems (avionics, sensors, electronic warfare, space payloads), Integrated Mission Systems (ISR, maritime, electro-optical), Communication Systems (tactical radios, secure communications), and, following its acquisition of Aerojet Rocketdyne, a propulsion segment that makes rocket motors and missile propulsion for the US military and space programs. L3Harris primarily sells to the US Department of Defense, allied governments, and intelligence agencies under long-term contracts, which gives it durable, often multi-year revenue backed by defense budgets. It makes money by designing, building, and supporting mission-critical hardware and software, then earning long-tail revenue from sustainment, upgrades, and spare parts. The company also pursues cost-savings programs to expand margins after its large merger and acquisitions. Over the trailing twelve months to early October 2026 it generated about $23.3 billion of revenue (up about 7.1% year over year in the latest quarter) and about $2.0 billion of net income. In its third quarter of 2026 revenue reached about $6.06 billion and EPS of $3.28 came in above the roughly $2.95 consensus, after $3.13 against $2.80 in the second quarter. In October 2026 it signed a teaming agreement with Divergent Technologies to raise production of lower-cost munitions. Headquartered in Melbourne, Florida, with about 45,000 employees.

Full LHX guide

ESLT vs LHX: how do they differ?

Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.

  • ESLT drivers: Record backlog and revenue visibility; European rearmament tailwind.
  • LHX drivers: Rising global defense spending; Diversified mission-critical portfolio.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: The most cited risk is valuation: ESLT trades at about 47 times trailing earnings and 33 times forward earnings as of November 20, 2026, far above the industrials-sector average, so disappointing execution could compress the multiple sharply. For LHX, l3Harris depends heavily on US government and allied defense budgets, so spending cuts, continuing resolutions, government shutdowns, or shifting priorities directly threaten revenue.

ESLT or LHX: which should you pick?

If the story you believe is ESLT's (Record backlog and revenue visibility), ESLT is the more direct way to own it; if it is LHX's (Rising global defense spending), LHX is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ESLT and LHX guides.

ESLT vs LHX: the full fundamentals

ESLT. As of November 20, 2026, ESLT traded at about $666 per share with a market cap near $31 billion, roughly 47 times trailing earnings and 33 times forward earnings, with EV/EBITDA near 30x. The premium reflects a record backlog, mid-to-high-teens revenue growth and five straight earnings beats, though the multiple has come down from the October level as the share price fell. Analysts expect 2026 EPS of about $17.07 and 2027 EPS of about $20.37, on revenue of about $9.17 billion and $10.72 billion.

LHX. At about $255 a share on November 20, 2026, L3Harris trades near 24 times trailing earnings but about 19 times forward earnings, because analysts expect EPS to keep growing at a low-double-digit pace into 2027 (about $13.65). The share price has fallen about 16% in 2026 while earnings rose and the last five quarters all beat estimates, so the multiple has compressed with sector sentiment rather than with the results. The analyst mean target of about $334 across 21 analysts sits well above the current price, though several firms have trimmed targets since October.

Headline figures (approximate, November 2026): ESLT shows revenue (ttm) ~$8.9B, revenue growth (q3 2026, yoy) ~17%, margins (operating / net, ttm) ~9.7% / ~7.7%, eps (ttm) ~$14.19; LHX shows revenue (ttm) ~$23.3 billion, revenue growth (q3 2026, yoy) ~7.1%, operating margin ~13.3%, net income (ttm) ~$2.0 billion (EPS ~$10.74).

The bottom line: ESLT vs LHX

ESLT and LHX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined ESLT and LHX exposure against your real portfolio. It is not an investment adviser.

Wondering how ESLT or LHX fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Elbit Systems Ltd

Ask Walnut's AI anything about ESLT and see how it fits what you own.

FAQ

What is the difference between ESLT and LHX?

+

Elbit Systems Ltd (Nasdaq and Tel Aviv: ESLT) is an Israel-based defense technology company that develops, manufactures, integrates and sustains military systems across land, sea, air, cyber and space domains. L3Harris Technologies is a major US defense and aerospace contractor formed by the 2019 merger of L3 Technologies and Harris Corporation. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is ESLT or LHX the better stock?

+

Neither is universally better. LHX is the larger incumbent; ESLT is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, ESLT or LHX?

+

On forward P/E (as of November 2026), ESLT trades at 32.69x and LHX at 18.68x, so LHX is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both ESLT and LHX?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of ESLT vs LHX?

+

ESLT: The most cited risk is valuation: ESLT trades at about 47 times trailing earnings and 33 times forward earnings as of November 20, 2026, far above the industrials-sector average, so disappointing execution could compress the multiple sharply. The stock has already fallen roughly 34% from its 52-week high, and the analyst consensus among six analysts is a hold with a mean target near $837. Israel-specific geopolitical and reputational exposure is real, as some European governments have at times restricted or scrutinized arms purchases from Israeli suppliers, and ESG-driven divestment pressure has surfaced; Israeli elections and Iran-related tensions add headline risk. On the Q3 call management fielded questions about a potential end of US military aid to Israel, a policy question that could affect part of the Israeli defense budget. The company also carries currency exposure to the Israeli shekel and depends on sustained elevated global defense spending, which could soften if conflicts de-escalate or budgets are reprioritized. A shelf prospectus filed in Israel in September 2026 leaves room for future securities issuance. Program delays, supply-chain constraints and heavy reliance on government customers add execution and concentration risk. LHX: L3Harris depends heavily on US government and allied defense budgets, so spending cuts, continuing resolutions, government shutdowns, or shifting priorities directly threaten revenue. Large fixed-price development programs can run over budget and hurt margins. Integrating major acquisitions like Aerojet Rocketdyne carries execution risk, and the balance sheet carries about $11 billion of debt against about $3.0 billion of cash. Program delays, cost overruns, supply-chain constraints, and procurement protests are recurring risks. Defense stocks can also de-rate on hopes for reduced geopolitical tension, political pressure on the defense budget, or competition from venture-backed entrants such as Anduril, whose private valuation drew attention in October 2026. That de-rating is visible now: LHX is down about 16% in 2026 and about 10% over one year as of November 20, trading in the lower part of its $232-379 52-week range, and RBC and Bernstein cut price targets in mid-October, followed by Seaport Global (to $393 from $443) in November. Program-level competition shows up too: in November 2026 Jefferies called Raytheon's move to dual-source a Tomahawk component a modest incremental negative for L3Harris.

Related comparisons

Browse all stock comparisons.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ESLT or LHX; figures are approximate and dated (as of November 2026). Verify current data before investing.